Arpeggio Bio: site gone or moved, 10 Jul 2026
Arpeggio Bio develops drugs targeting transcription factors using AI…
Public prices for a whole company's records run $132K to $485K per company in the middle of the market, and the highest public offer for one company's archive is $12.5M. What a closed company's records fetch depends on how many people wrote them, over how many years, and whether its accounts are still open: buyers pay for linked histories (code with its tickets, decisions with their discussion), and the deletion clock runs from the day the subscriptions stop.
Value the records of Arpeggio Bio in a few minutes (free; for whoever owns them now)
- Founded
- 2018
- Team
- 20 people, as listed
- Y Combinator
- Summer 2019
- Industry
- Healthcare / Healthcare -> Drug Discovery and Delivery
- Country
- US
- In the archive since
- 12 Jun 2021
- Last worked
- 10 Jul 2026
- Months kept up
- 47
- Today
- Gone dark, checked 27 Oct 2026
- Zensors, 6 Oct 2026
- RocketLit, 20 Sep 2026
- Ping, 17 Jul 2026
- Cairns Health, 15 Jun 2026
- Nobell Foods, 14 Jun 2026
- Monet, 9 Jun 2026
About this page
Built each morning from public records only: no person is named and nothing private is used. Each signal links to its own record and to where it was read. If you represent Arpeggio Bio and something here is wrong, tell us and it is corrected the same day.